Legionnaires' dise4ase: macrolides or quinolones? (CROSBI ID 560670)
Prilog sa skupa u zborniku | sažetak izlaganja sa skupa
Podaci o odgovornosti
Kuzman, Ilija ; Puljiz, Ivan ; Skuhala, Tomislava
engleski
Legionnaires' dise4ase: macrolides or quinolones?
Our clinical experience shows that early antibiotic treatment with newer macrolides (azithromycin) and fluoroquinolones (moxifloxacin) was clinically very effective and essential for outcome of illness. The results suggest that moxifloxacin may have a superior clinical response compared to azithromycin with regards to defervescence,
Legionnaires' disease; macrolides; fluoroquinolones
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
29-30.
2009.
objavljeno
Podaci o matičnoj publikaciji
6th Croatian Congress on Infectious Diseases (abstract Book)
Podaci o skupu
6th Croatian Congress on Infectious Diseases
pozvano predavanje
24.10.2009-27.10.2009
Šibenik, Hrvatska